Exchange: OTC·Updated 11:30 AM EST

PAAFF Pharmaust Ltd.

$0.045
$0.006
(11.77%)
Today
Mkt Cap$38.49M
Vol200,000.00

About PAAFF

Neurizon Therapeutics Ltd. engages in the business of developing own drug discovery intellectual property for the treatment of different types of cancers, neurological diseases, and viral infections; and providing highly specialized medicinal and synthetic chemistry services on a contract basis to clients. It operates under the Corporate and Research segment. The Corporate and Research segment includes corporate overhead expenses. The company was founded on August 03, 2000 and is headquartered in Melbourne, Australia.
50

Sentiment

How do you feel about PAAFF?

Advertisement|Remove ads.